Geoffrey Playford

Evaluation of the ICT malaria P.f/P.v and the OptiMal rapid diagnostic tests for malaria in febrile returned travellers.

Antifungal agents for preventing fungal infections in solid organ transplant recipients.

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.

Simultaneous detection and identification of Candida, Aspergillus, and Cryptococcus species by reverse line blot hybridization.

Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients.

Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.

Optimizing therapy for Candida infections.

Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

Antifungals in the ICU.

Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients.

Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.

Management of invasive candidiasis in the intensive care unit.

Prophylaxis, empirical and preemptive treatment of invasive candidiasis.

Risk factors for urinary catheter associated bloodstream infection.

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.